OTC Markets EXMKT - Delayed Quote USD

Sunwin Stevia International, Inc. (SUWN)

Compare
0.0003 0.0000 (0.00%)
At close: August 30 at 4:00 PM EDT
Loading Chart for SUWN
DELL
  • Previous Close 0.0000
  • Open 0.0003
  • Bid --
  • Ask --
  • Day's Range 0.0003 - 0.0003
  • 52 Week Range 0.0001 - 0.0005
  • Volume 1,000
  • Avg. Volume 112
  • Market Cap (intraday) 59,889
  • Beta (5Y Monthly) -0.50
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It offers Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.

www.sunwininternational.com

242

Full Time Employees

April 30

Fiscal Year Ends

Recent News: SUWN

View More

Performance Overview: SUWN

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SUWN
200.00%
S&P 500
18.42%

1-Year Return

SUWN
25.00%
S&P 500
25.59%

3-Year Return

SUWN
99.18%
S&P 500
25.26%

5-Year Return

SUWN
99.40%
S&P 500
93.14%

Compare To: SUWN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SUWN

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    59.89k

  • Enterprise Value

    1.83M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    0.01

  • Enterprise Value/Revenue

    0.05

  • Enterprise Value/EBITDA

    -3.90

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.77%

  • Return on Assets (ttm)

    -3.64%

  • Return on Equity (ttm)

    -58.95%

  • Revenue (ttm)

    34M

  • Net Income Avi to Common (ttm)

    -1.62M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.77M

  • Total Debt/Equity (mrq)

    336.04%

  • Levered Free Cash Flow (ttm)

    4.26M

Research Analysis: SUWN

View More

Company Insights: SUWN

Research Reports: SUWN

View More

People Also Watch